NCT01320306

Brief Summary

The prevalence rate of intracranial aneurysms in the adult population is close to 5%. Rupture risk of such aneurysms causing subarachnoid hemorrhage (SAH) can be substantial.Most patients suffering from an aneurysmal SAH are in their mid life, i.e., 30 to 60 years old. Aneurysmal SAH may cause disability and mortality. The present study includes a follow-up study and a cross-sectional fMRI study. The purpose of the follow-up study is to monitor patients receiving prophylactic surgical treatment of their un-ruptured aneurysms to examine whether such treatment is associated with cognitive, psychosocial and/or neurologic sequela. The purpose of the cross-sectional fMRI study is to examine the relationship between memory function and brain activity among SAH patients. Memory impairment is often found among aneurysmal SAH patients. Using fMRI can possibly shed some light on whether such memory impairment may be caused by diffuse cerebral damage or a focal damage at the aneurysm site.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

March 18, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 22, 2011

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2012

Completed
Last Updated

April 26, 2019

Status Verified

May 1, 2012

Enrollment Period

11 months

First QC Date

March 18, 2011

Last Update Submit

April 24, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cognitive function

    Neuropsychological Assessment

    Each subject will undergo one assessment of cognitive function. The assessment lasts about 2.5 hours including breaks.

Secondary Outcomes (2)

  • Neurological status

    Each subject will undergo one clinical assessment of neurological status.

  • fMRI

    A subgroup of patients will participate in a fMRI study once

Study Arms (4)

Subarachnoid hemorrhage

A group of patients suffering aneurismal subarachnoid hemorrhage will participate in a fMRI study.

Prophylactic surgical treatment of un-ruptured aneurysms

A retrospective follow-up study of patients who have received prophylactic surgical treatment of un-ruptured aneurysms

Conservative treatment

A retrospective follow-up of patients receiving conservative (life stile etc.) treatment of un-ruptured aneurysms.

Control group of healthy subjects

Control group of healthy subjects

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with un-ruptured aneurysms in the anterior communicating artery and the middle cerebral artery.A subgroup of patients suffering aneurismal subarachnoid hemorrhage. University Hospital of North Norway

You may qualify if:

  • Patients with un-ruptured aneurysms in the anterior communicating artery and the middle cerebral artery.
  • A subgroup of patients suffering aneurismal subarachnoid hemorrhage.

You may not qualify if:

  • History of earlier cerebrovascular, psychiatric or neurological disease.
  • Age older than 75 years
  • Lack of fluency in Norwegian
  • Alcohol or Substance abuse
  • Aphasia
  • Substantial vision or hearing deficits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of North Norway

Tromsø, N-9038, Norway

Location

Related Publications (2)

  • Isaksen JG, Bazilevs Y, Kvamsdal T, Zhang Y, Kaspersen JH, Waterloo K, Romner B, Ingebrigtsen T. Determination of wall tension in cerebral artery aneurysms by numerical simulation. Stroke. 2008 Dec;39(12):3172-8. doi: 10.1161/STROKEAHA.107.503698. Epub 2008 Sep 25.

    PMID: 18818402BACKGROUND
  • Sandell T, Isaksen J, Bajic R, Ingebrigtsen T. [Treatment of intracranial aneurysms]. Tidsskr Nor Laegeforen. 2005 Aug 25;125(16):2188-91. Norwegian.

    PMID: 16138132BACKGROUND

MeSH Terms

Conditions

Intracranial Aneurysm

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular Diseases

Study Officials

  • Tor Ingebrigtsen, Phd

    University Hospital of North Norway

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2011

First Posted

March 22, 2011

Study Start

March 1, 2011

Primary Completion

January 31, 2012

Study Completion

January 31, 2012

Last Updated

April 26, 2019

Record last verified: 2012-05

Locations